Twelve weeks of pioglitazone therapy significantly attenuates dysmetabolism and reduces inflammation in continuous ambulatory peritoneal dialysis patients--a randomized crossover trial - Li, Y; Xie, QH; You, HZ (Perit Dial Int, 2012)